Device type · DTR
Heat-Exchanger, Cardiopulmonary Bypass
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
DTR
Cardiovascular
Device class
Class II
FDA decisions since 2015
12
510(k), De Novo and PMA
Adverse event reports
45
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Heat-Exchanger, Cardiopulmonary Bypass
- Product code
- DTR
- Device class
- Class II
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.4240
- Specialty
- Cardiology
- FDA record
- Classification database entry for DTR
Latest FDA decisions
The 8 newest of 12 since 2015.
K252541 · Decided Mar 12, 2026 · 212 days after receipt
Device type: Heat-Exchanger, Cardiopulmonary Bypass (DTR) · Cardiology
- Quantum Micro-Cardioplegia Delivery System; Quantum Micro-Cardioplegia Delivery Module (QMCDM)510(k)
K240908 · Decided Jul 8, 2025 · 462 days after receipt
Device type: Heat-Exchanger, Cardiopulmonary Bypass (DTR) · Cardiology
K250150 · Decided May 30, 2025 · 129 days after receipt
Device type: Heat-Exchanger, Cardiopulmonary Bypass (DTR) · Cardiology
K240190 · Decided Feb 23, 2024 · 30 days after receipt
Device type: Heat-Exchanger, Cardiopulmonary Bypass (DTR) · Cardiology
K223879 · Decided Apr 13, 2023 · 107 days after receipt
Device type: Heat-Exchanger, Cardiopulmonary Bypass (DTR) · Cardiology
K220110 · Decided May 6, 2022 · 113 days after receipt
Device type: Heat-Exchanger, Cardiopulmonary Bypass (DTR) · Cardiology
K212688 · Decided Jan 10, 2022 · 138 days after receipt
Device type: Heat-Exchanger, Cardiopulmonary Bypass (DTR) · Cardiology
K201984 · Decided Nov 20, 2020 · 126 days after receipt
Device type: Heat-Exchanger, Cardiopulmonary Bypass (DTR) · Cardiology
Reports received
45
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
35
78% of reports
Injury reports
10
22% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1 | 0 | 0 | 0 |
| Jan 24 | 0 | 1 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 2 | 0 | 0 | 0 |
| Apr 24 | 0 | 1 | 0 | 0 |
| May 24 | 1 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 1 | 0 | 0 | 0 |
| Sep 24 | 1 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 1 | 0 | 0 | 0 |
| Jan 25 | 0 | 1 | 0 | 0 |
| Feb 25 | 5 | 0 | 0 | 0 |
| Mar 25 | 1 | 0 | 0 | 0 |
| Apr 25 | 3 | 0 | 0 | 0 |
| May 25 | 3 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 4 | 0 | 0 | 0 |
| Aug 25 | 1 | 0 | 0 | 0 |
| Sep 25 | 2 | 0 | 0 | 0 |
| Oct 25 | 3 | 5 | 0 | 0 |
| Nov 25 | 6 | 1 | 0 | 0 |
| Dec 25 | 6 | 3 | 0 | 0 |
| Jan 26 | 2 | 3 | 0 | 0 |
| Feb 26 | 8 | 0 | 0 | 0 |
| Mar 26 | 2 | 0 | 0 | 0 |
| Apr 26 | 1 | 2 | 0 | 0 |
| May 26 | 7 | 0 | 0 | 0 |
| Jun 26 | 2 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 1 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 1 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Fluid/Blood Leak16
- Mechanical Problem8
- Tear, Rip or Hole in Device Packaging8
- Leak/Splash6
- Insufficient Device Problem Information4
- No Apparent Adverse Event4
- Infusion or Flow Problem3
- Device Contaminated During Manufacture or Shipping2
- Manufacturing, Packaging or Shipping Problem2
- Air/Gas in Device1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions37
- Hemorrhage/Blood Loss/Bleeding7
- Insufficient Information1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-3327-2026 · Started Jul 17, 2026 · Posted by FDA Sep 29, 2026
Reason given: Due to blood-to-glycol leak in the heat exchanger.
Cause as FDA categorized it: Process design
Z-3328-2026 · Started Jul 17, 2026 · Posted by FDA Sep 29, 2026
Reason given: Due to blood-to-glycol leak in the heat exchanger.
Cause as FDA categorized it: Process design
- QUADROX-i Pediatric, Oxygenator used during cardiopulmonary bypass Model Item No. HMO 30000-USA 701070384 HMO 31000-USA 701070388Open, Classified
Z-1641-2023 · Started May 18, 2023 · Posted by FDA May 26, 2023
Reason given: 1. An accessory may be improperly placed during packaging, causing creases and damage to the accessory's sterile pouch. 2. Product packaging may exhibit holes, cracks, dents, and crushed areas. Both issues may compromise the sterile barrier of the packaging, and exposure to non-sterile product may result in...
Cause as FDA categorized it: Pending
Z-2107-2020 · Started Dec 17, 2019
Reason given: Additive and Arrest Agent Labels on the MPS Top Cover Replacement Kit, a replacement for worn or damaged MPS Console Top Covers for cardiopulmonary bypass heat exchanger, used to deliver whole blood to the heart during open heart surgery, were swapped and incorrectly placed. This could lead to over delivery of...
Cause as FDA categorized it: Under Investigation by firm
Z-0361-2016 · Started Oct 28, 2015 · Posted by FDA Dec 2, 2015
Reason given: The products have been found to intermittently exhibit a seal failure during use.
Cause as FDA categorized it: Equipment maintenance
Maquet Cardiovascular Us Sales, Llc
Z-1165-2014 · Started Jan 31, 2014 · Posted by FDA Mar 10, 2014
Reason given: The MAQUET post-marketing vigilance program has identified a discrepancy that the desired cardioplegia temperature may not be obtained when the PLEGIOX Cardioplegia Heat Exchanger (PLEGIOX) is used in conjunction with a heater/cooler unit.
Cause as FDA categorized it: Device Design
Terumo Cardiovascular Systems Corp
Z-0156-2015 · Started Mar 1, 2011 · Posted by FDA Oct 31, 2014
Reason given: Defect in the luer connector can compromise the seal on the female side of the connector and the compromised seal can introduce air in the table line
Cause as FDA categorized it: Device Design
Terumo Cardiovascular Systems Corp
Z-0158-2015 · Started Mar 1, 2011 · Posted by FDA Oct 31, 2014
Reason given: Defect in the luer connector can compromise the seal on the female side of the connector. and the compromised seal can introduce air in the table line
Cause as FDA categorized it: Device Design
Showing the 8 newest of 35 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.